GLA and Fabry disease: The identification of novel mutations through a well-performed screening represents an important goal nowadays, not only for increasing molecular knowledge of GLA gene but especially for the important clinical implications derived from the detection of asymptomatic or not very symptomatic patients with FD in a very early phase.